Am Fam Physician. 2001 Jan 15;63(2):225.
to the editor: The recent article entitled “Age-related Macular Degeneration: Update for Primary Care”1 is a good overview of the subject, but it underemphasizes the role that smoking plays as a risk factor for age-related macular degeneration (AMD). Of the potential risk factors for AMD, only smoking has been demonstrated to be associated with the disease consistently across studies of different design and within different populations.2 Another recent study3 on cardiovascular risk factors and AMD reported that the only factors significantly associated with age-related maculopathy included smoking (odds ratio: 4.1) and family history (odds ratio: 4.2). Many other studies confirm the strong association between smoking and AMD.
Smoking cessation is, therefore, potentially of great benefit in preventing AMD. Because the risk of AMD conferred by smoking remains strong even up to 20 years after smoking cessation,4 physicians should discuss the potential for smoking-related AMD as a risk factor early on in our attempts to help patients stop smoking.
REFERENCESshow all references
1. Fong DS. Age-related macular degeneration: update for primary care. Am Fam Physician. 2000;61:3035–42....
2. Hawkins BS, Bird A, Klein R, West SK. Epidemiology of age-related macular degeneration. Mol Vis. 1999;5:26.
3. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol. 1998;116:583–7.
4. Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l'Age. Arch Ophthalmol. 1998;116:1031–5.
in reply: I agree with Dr. Houston that smokers should be counseled about the dangers of smoking. As discussed in Table 1 of my article,1 smoking is an established risk factor for age-related macular degeneration (AMD). Prevention of AMD is one additional reason why patients who smoke should stop.
1. Fong DS. Age-related macular degeneration: update for primary care. Am Fam Physician. 2000;61:3035–42.
Send letters to firstname.lastname@example.org, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680. Include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the AAFP permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
This series is coordinated by Kenny Lin, MD, MPH, Associate Deputy Editor for AFP Online.
Copyright © 2001 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions